Trial Profile
A retrospective study to assess use of apremilast in combination with photo-, systemic, or biologic therapy in patients with chronic plaque psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Aug 2017
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 01 Aug 2017 New trial record